Chugai Pharmaceutical Co., Ltd. is a prominent pharmaceutical company involved in research, development, manufacturing, and marketing of a wide range of pharmaceutical products. Its primary aim is to ... Chugai Pharmaceutical Co., Ltd. is a prominent pharmaceutical company involved in research, development, manufacturing, and marketing of a wide range of pharmaceutical products. Its primary aim is to advance the field of medicine by focusing on the development of innovative therapies that address unmet medical needs. Chugai operates primarily in the fields of oncology, renal disease, and bone and joint diseases, leveraging its capabilities in biotechnology antibody pharmaceuticals. Notably, the company collaborates closely with Roche Group, enabling it to leverage advanced science and technology in drug discovery and development. Chugai's influence is significant in both Japanese and global markets, as it continues to contribute to the enhancement of healthcare by providing high-quality pharmaceutical solutions. Founded in 1925, Chugai is strongly committed to its mission of providing valuable products and services that align with the needs of patients and healthcare providers worldwide.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Chugai Pharmaceutical is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Chugai Pharmaceutical is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Chugai Pharmaceutical's data?

Create a free Tracenable account to signal interest in having our team review data for Chugai Pharmaceutical.

Legal Center Contact Us